Effect of luteinizing hormone on follicle stimulating hormone-activated paracrine signalling in rat ovary

'Pure' follicle stimulating hormone (FSH) and luteinizing hormone (LH) are expected shortly to become available for pharmaceutical use in the clinical setting. To test the contribution of LH to optimal ovarian responsiveness to FSH, 21-day-old hypophysectomized, immature, female rats recei...

Full description

Saved in:
Bibliographic Details
Published inHuman reproduction (Oxford) Vol. 10; no. 1; p. 33
Main Authors Smyth, C D, Miró, F, Howles, C M, Hillier, S G
Format Journal Article
LanguageEnglish
Published England 01.01.1995
Subjects
Online AccessGet more information

Cover

Loading…
Abstract 'Pure' follicle stimulating hormone (FSH) and luteinizing hormone (LH) are expected shortly to become available for pharmaceutical use in the clinical setting. To test the contribution of LH to optimal ovarian responsiveness to FSH, 21-day-old hypophysectomized, immature, female rats received four s.c. injections of recombinant human LH (rhLH; total dose 1-10 IU) and/or rhFSH (total dose 30-72 IU) given at 12-hourly intervals. At 48 h after the first injection, ovaries were removed, weighed and used to isolate granulosa and thecal/interstitial cells for assessment of basal and gonadotrophin-responsive steroidogenesis in vitro, or homogenized to extract total RNA for Northern analysis of 17-hydroxylase/C17-20-lyase (cytochrome P-450c17 alpha) mRNA. Serum oestradiol and uterine weight were measured as indices of ovarian oestrogen production; androstenedione was measured to reflect ovarian androgen production. Consistent with the two-cell, two-gonadotrophin model of oestrogen synthesis, increased ovarian oestrogen secretion only occurred if both rhFSH and rhLH were given simultaneously. Treatment with rhFSH alone stimulated ovarian weight gain and granulosa cell aromatase activity without oestrogen secretion, whereas rhLH alone stimulated thecal androgen synthesis and androgen secretion. When the total rhLH dose was fixed at 1 IU, giving rise to an unmeasurably low serum concentration of rhLH, additional treatment with rhFSH (30-72 IU) dose-dependently stimulated serum androgen concentrations as well as oestrogen concentrations. The approximately 2.0 kb-sized P-450c17 alpha mRNA transcript was undetectable in the ovaries of untreated control animals but was abundant in the ovaries of positive controls treated with 15 IU of pregnant mare serum gonadotrophin.
AbstractList 'Pure' follicle stimulating hormone (FSH) and luteinizing hormone (LH) are expected shortly to become available for pharmaceutical use in the clinical setting. To test the contribution of LH to optimal ovarian responsiveness to FSH, 21-day-old hypophysectomized, immature, female rats received four s.c. injections of recombinant human LH (rhLH; total dose 1-10 IU) and/or rhFSH (total dose 30-72 IU) given at 12-hourly intervals. At 48 h after the first injection, ovaries were removed, weighed and used to isolate granulosa and thecal/interstitial cells for assessment of basal and gonadotrophin-responsive steroidogenesis in vitro, or homogenized to extract total RNA for Northern analysis of 17-hydroxylase/C17-20-lyase (cytochrome P-450c17 alpha) mRNA. Serum oestradiol and uterine weight were measured as indices of ovarian oestrogen production; androstenedione was measured to reflect ovarian androgen production. Consistent with the two-cell, two-gonadotrophin model of oestrogen synthesis, increased ovarian oestrogen secretion only occurred if both rhFSH and rhLH were given simultaneously. Treatment with rhFSH alone stimulated ovarian weight gain and granulosa cell aromatase activity without oestrogen secretion, whereas rhLH alone stimulated thecal androgen synthesis and androgen secretion. When the total rhLH dose was fixed at 1 IU, giving rise to an unmeasurably low serum concentration of rhLH, additional treatment with rhFSH (30-72 IU) dose-dependently stimulated serum androgen concentrations as well as oestrogen concentrations. The approximately 2.0 kb-sized P-450c17 alpha mRNA transcript was undetectable in the ovaries of untreated control animals but was abundant in the ovaries of positive controls treated with 15 IU of pregnant mare serum gonadotrophin.
Author Hillier, S G
Howles, C M
Smyth, C D
Miró, F
Author_xml – sequence: 1
  givenname: C D
  surname: Smyth
  fullname: Smyth, C D
  organization: Reproductive Endocrinology Laboratory, University of Edinburgh, UK
– sequence: 2
  givenname: F
  surname: Miró
  fullname: Miró, F
– sequence: 3
  givenname: C M
  surname: Howles
  fullname: Howles, C M
– sequence: 4
  givenname: S G
  surname: Hillier
  fullname: Hillier, S G
BackLink https://www.ncbi.nlm.nih.gov/pubmed/7745066$$D View this record in MEDLINE/PubMed
BookMark eNpNj0tLAzEQx4NUalu9ehPyBbbNa5PsUUp9QMGLnstsNmkju9klmy3opzdiD55mhv_jxyzRLPTBInRPyZqSim9OUxftsPk915xfoQUVkhSMl2SGFoRJXVAq6Q1ajuMnIXnVco7mSomSSLlAfuecNQn3DrdTsj74bx-O-NTHLnNwH7Dr29ab1uIx-W5qIf3TCzDJnyHZBg8QwUSfM6M_BsiZbPMBR8jlZ4hft-jaQTvau8tcoY-n3fv2pdi_Pb9uH_eF4ZVKRSNtpYyjIKuS6VpLQyllAoRoGsKp5EzZkikjpHZCG9rYEsBVtTJKVkRptkIPf73DVHe2OQzRdxl_uLzMfgC9qVzW
CitedBy_id crossref_primary_10_1016_S1472_6483_10_61991_8
crossref_primary_10_1155_2015_925691
crossref_primary_10_1093_humrep_del408
crossref_primary_10_1095_biolreprod63_4_1214
crossref_primary_10_1210_jc_2009_0262
crossref_primary_10_1016_S0303_7207_01_00469_5
crossref_primary_10_1002_mrd_10107
crossref_primary_10_1016_j_fertnstert_2013_04_016
crossref_primary_10_1016_S0950_3552_97_80036_3
crossref_primary_10_1038_jhg_2016_82
crossref_primary_10_1093_molehr_gap086
crossref_primary_10_1210_me_2011_1341
crossref_primary_10_1016_j_jep_2003_12_024
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1093/humrep/10.1.33
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1460-2350
ExternalDocumentID 7745066
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-E4
.2P
.55
.GJ
.I3
.XZ
.ZR
0R~
1TH
29I
2WC
3O-
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
6.Y
70D
AABZA
AACZT
AAIMJ
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AARHZ
AASNB
AAUQX
AAVAP
AAVLN
AAWDT
AAYOK
ABEUO
ABIXL
ABJNI
ABKDP
ABMNT
ABNHQ
ABNKS
ABPTD
ABQLI
ABQNK
ABQTQ
ABSAR
ABSMQ
ABWST
ABXVV
ABZBJ
ACCCW
ACFRR
ACGFS
ACIMA
ACMRT
ACPQN
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADEZT
ADGKP
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEJOX
AEKPW
AEKSI
AELWJ
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFNX
AFFZL
AFGWE
AFIYH
AFOFC
AFXAL
AFXEN
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGQXC
AGSYK
AGUTN
AHMBA
AHXPO
AIJHB
AIMBJ
AJEEA
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ANFBD
APIBT
APWMN
AQDSO
AQKUS
ARIXL
ASAOO
ASMCH
ASPBG
ATDFG
ATTQO
AVNTJ
AVWKF
AWCFO
AXUDD
AYOIW
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BGYMP
BHONS
BQDIO
BSWAC
BTRTY
BVRKM
BYORX
BZKNY
C1A
C45
CAG
CDBKE
CGR
COF
CS3
CUY
CVF
CXTWN
CZ4
DAKXR
DFGAJ
DIK
DILTD
DU5
D~K
E3Z
EBS
ECM
EE~
EIF
EIHJH
EJD
ELUNK
EMOBN
ENERS
F5P
F9B
FECEO
FEDTE
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H5~
HAR
HVGLF
HW0
HZ~
IOX
J21
JXSIZ
KAQDR
KBUDW
KC5
KOP
KQ8
KSI
KSN
L7B
M-Z
M49
MBLQV
MBTAY
MHKGH
ML0
N9A
NGC
NLBLG
NOMLY
NOYVH
NPM
NTWIH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OBOKY
OCZFY
ODMLO
OHT
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RIG
RNI
ROL
ROX
ROZ
RUSNO
RW1
RXO
RZF
RZO
TCN
TCURE
TEORI
TJX
TLC
TMA
TR2
W8F
WH7
WOQ
X7H
X7M
YAYTL
YKOAZ
YXANX
ZGI
ZKX
ZXP
~91
ID FETCH-LOGICAL-c397t-d6e97cf1a69528b86c11124a44dd0316327e527c468f48c1de5aaf9b7c7690782
ISSN 0268-1161
IngestDate Thu May 23 23:52:54 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c397t-d6e97cf1a69528b86c11124a44dd0316327e527c468f48c1de5aaf9b7c7690782
OpenAccessLink http://doc.rero.ch/record/294913/files/10-1-33.pdf
PMID 7745066
ParticipantIDs pubmed_primary_7745066
PublicationCentury 1900
PublicationDate 1995-Jan
PublicationDateYYYYMMDD 1995-01-01
PublicationDate_xml – month: 01
  year: 1995
  text: 1995-Jan
PublicationDecade 1990
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Human reproduction (Oxford)
PublicationTitleAlternate Hum Reprod
PublicationYear 1995
SSID ssj0016186
Score 1.6083432
Snippet 'Pure' follicle stimulating hormone (FSH) and luteinizing hormone (LH) are expected shortly to become available for pharmaceutical use in the clinical setting....
SourceID pubmed
SourceType Index Database
StartPage 33
SubjectTerms Aldehyde-Lyases - genetics
Androstenedione - biosynthesis
Animals
Aromatase - metabolism
Cytochrome P-450 Enzyme System - genetics
Drug Interactions
Female
Follicle Stimulating Hormone - administration & dosage
Granulosa Cells - drug effects
Granulosa Cells - enzymology
Hormones - blood
Humans
Luteinizing Hormone - administration & dosage
Organ Size - drug effects
Ovary - anatomy & histology
Ovary - drug effects
Ovary - metabolism
Rats
Rats, Wistar
Recombinant Proteins - administration & dosage
RNA, Messenger - genetics
RNA, Messenger - metabolism
Steroid 17-alpha-Hydroxylase
Theca Cells - drug effects
Theca Cells - metabolism
Uterus - anatomy & histology
Uterus - drug effects
Title Effect of luteinizing hormone on follicle stimulating hormone-activated paracrine signalling in rat ovary
URI https://www.ncbi.nlm.nih.gov/pubmed/7745066
Volume 10
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEBWblpZcSrtp6Dc6lFwSbWxJluVjWlqWwoYeNpBbkGWZGLLeQDeBzT_pv-1Io9rebFvaXoyxbFn2PI9Ho5k3hLxXtk5yVygmbC2ZJ-xipuYpUyazRVIVwob0sdmpmp7JL-fZ-Wj0fRC1dLMqJ_bul3kl_yNVOAZy9Vmy_yDZrlM4APsgX9iChGH7VzKO1MNg78FdXNM2d37ifwlm6BJsxxBDeHXlLzqED3kRCnX17cynNNwab3F6_m_r0wAPfTiHQZpun-hioPNbs5k1jW5_T4YZuGIRPhoTDwd-heA1DW7YPqh41oSF-Q9iI6R42hXeHvpmvR8oFgWL9b-qmKyXDXwTqMK4gjlqinTrE4cqVqqEcYF0s50OTrawhgoVWTK29DxyYF3eLOBp0feQTjZPBUldL4LcwcDNEizt8sfGe7zbsWWH7OTaq85T7waKy1O-yAA67_DxOjZQcYxjOo4j2iWPYj_3pi3BfJk_JU_ivIOeIIiekZFrx2TvpDWr5WJND2iIBA5LLGPyeBYDLsbk4CtSm6-P6LzP1Pt2FK7oSM_Xe6RBLNJlTQdYpBFrdNnSn1ikAyzSLSzSDou0xyJtWgpYpAGLz8nZ50_zj1MWy3gwC8builXKFbmtU6OKjOtSKwv_Vy6NlFUFvxQleO4ynlupdC21TSuXGVMXZW5z77rRfJ88aGEoLwhNs1JoOK0SopaGJ2BsG-NMbktTOl2Kl2QfX_LFNXK1XMS3_-p3Da_Jbg_cN-RhDarBvQU7c1W-CzL_AXr7flk
link.rule.ids 786
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+luteinizing+hormone+on+follicle+stimulating+hormone-activated+paracrine+signalling+in+rat+ovary&rft.jtitle=Human+reproduction+%28Oxford%29&rft.au=Smyth%2C+C+D&rft.au=Mir%C3%B3%2C+F&rft.au=Howles%2C+C+M&rft.au=Hillier%2C+S+G&rft.date=1995-01-01&rft.issn=0268-1161&rft.eissn=1460-2350&rft.volume=10&rft.issue=1&rft.spage=33&rft_id=info:doi/10.1093%2Fhumrep%2F10.1.33&rft_id=info%3Apmid%2F7745066&rft_id=info%3Apmid%2F7745066&rft.externalDocID=7745066
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0268-1161&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0268-1161&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0268-1161&client=summon